What is Apogee Therapeutics, Inc. Common Stock's Market Cap?

Apogee Therapeutics, Inc. Common Stock's Market Cap is $10.2B, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's Enterprise Value?

Apogee Therapeutics, Inc. Common Stock's Enterprise Value is $9.3B, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's EV / EBITDA?

Apogee Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's Net Income (TTM)?

Apogee Therapeutics, Inc. Common Stock's Net Income (TTM) is -$294.4M, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's EBITDA?

Apogee Therapeutics, Inc. Common Stock's EBITDA is -$326.5M, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Apogee Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.89, based on as-reported figures from SEC (XBRL) filings.

What is Apogee Therapeutics, Inc. Common Stock's Net Debt?

Apogee Therapeutics, Inc. Common Stock's Net Debt is -$971.9M, based on as-reported figures from SEC (XBRL) filings.

Apogee Therapeutics, Inc. Common Stock (APGE) Financial Statements

Apogee Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG01H51WZL7

XNAS · usd

135.07▼ 0.01 (-0.01%)

As of 2026-09-02

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close135.08

Day's Range135.06 – 135.09

52-Week Range35.39 – 135.09

Volume5.1M

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees261

ExchangeXNAS

Listed2023-07-14

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Apogee Therapeutics, Inc. Common Stock (APGE)

What is Apogee Therapeutics, Inc. Common Stock's Market Cap?: Apogee Therapeutics, Inc. Common Stock's Market Cap is $10.2B, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's Enterprise Value?: Apogee Therapeutics, Inc. Common Stock's Enterprise Value is $9.3B, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's EV / EBITDA?: Apogee Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's Net Income (TTM)?: Apogee Therapeutics, Inc. Common Stock's Net Income (TTM) is -$294.4M, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's EBITDA?: Apogee Therapeutics, Inc. Common Stock's EBITDA is -$326.5M, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Apogee Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.89, based on as-reported figures from SEC (XBRL) filings.
What is Apogee Therapeutics, Inc. Common Stock's Net Debt?: Apogee Therapeutics, Inc. Common Stock's Net Debt is -$971.9M, based on as-reported figures from SEC (XBRL) filings.